Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics-Reference-Cited by-同舟云学术

Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics

Published:2023-05-01 Issue:6 Volume:102 Page:1549-1559
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Yamasaki Satoshi^ORCID,Mizuno Shohei,Iwasaki Makoto,Seo Sachiko,Uchida Naoyuki,Shigesaburo Miyakoshi,Nakano Nobuaki,Ishiwata Kazuya,Uehara Yasufumi,Eto Tetsuya,Takase Ken,Kawakita Toshiro,Tanaka Masatsugu,Sawa Masashi,Katayama Yuta,Nawa Yuichiro,Makoto Onizuka,Ichinohe Tatsuo,Atsuta Yoshiko,Kanda Junya,Yanada Masamitsu

Funder

JSPS KAKENHI

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05243-0.pdf

Reference35 articles.

1. Yanada M (2021) The evolving concept of indications for allogeneic hematopoietic cell transplantation during first complete remission of acute myeloid leukemia. Bone Marrow Transplant 56:1257–1265. https://doi.org/10.1038/s41409-021-01247-4

2. Walter RB, Othus M, Borthakur G, Ravandi F, Cortes JE, Pierce SA, Appelbaum FR, Kantarjian HA, Estey EH (2011) Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol 29:4417–4423. https://doi.org/10.1200/JCO.2011.35.7525

3. Tiercy JM (2016) How to select the best available related or unrelated donor of hematopoietic stem cells? Haematologica 101:680–687. https://doi.org/10.3324/haematol.2015.141119

4. Yanada M, Kurosawa S, Yamaguchi T, Uchida N, Miyawaki S, Kanamori H, Usuki K, Kobayashi T, Watanabe M, Nagafuji K, Yano S, Nawa Y, Tomiyama J, Tashiro H, Nakamura Y, Fujisawa S, Kimura F, Emi N, Miura I, Fukuda T (2013) Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation. Bone Marrow Transplant 48:390–395. https://doi.org/10.1038/bmt.2012.159

5. Yanada M, Takami A, Yamasaki S, Arai Y, Konuma T, Uchida N, Najima Y, Fukuda T, Tanaka M, Ozawa Y, Ikegame K, Takanashi M, Ichinohe T, Okamoto S, Atsuta Y, Yano S (2020) Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century. Ann Hematol 99:1351–1360. https://doi.org/10.1007/s00277-020-04051-0